Literature DB >> 21318040

Multimodal treatment of osteogenic sarcoma of the jaw.

Marton König1, Jon Mork, Kirsten S Hall, Terje Osnes, Torstein R Meling.   

Abstract

Osteosarcomas (OSs) account for 40 to 60% of primary malignant bone tumors. About 10% occur in the head and neck region, frequently in the mandibula or maxilla. We treated a 30-year-old patient with 26-month history of right-sided facial pain and paresthesia. Investigation showed high-grade OS of the right mandibular coronoid process, affecting the mandibular nerve, middle cranial fossa, internal jugular vein, and internal carotid artery (ICA). True en bloc resection was performed after upfront adjuvant chemotherapy. The ICA was trap-ligated intradurally, whereafter the floor of the middle fossa, including the mandibular nerve and the glenoid fossa, was detached from the skull base in one piece. Subsequently, a hemimandibulectomy, total parotidectomy, ICA sacrifice, and removal of the pterygoid plates and muscles were performed, and the abovementioned structures were removed as a solitary specimen, including the facial nerve branches overlying the tumor. A sural nerve graft was interposed between five major facial nerve branches to reanimate the face. The patient had an uneventful recovery, is able to eat, and has a partial facial nerve palsy. He has no tumor recurrence 26 months after surgery. OS of the jaw should be treated with radical surgery as the primary modality.

Entities:  

Keywords:  Osteosarcoma; craniofacial surgery; en bloc resection; jaw tumor; tumor of the skull base

Year:  2010        PMID: 21318040      PMCID: PMC3037111          DOI: 10.1055/s-0029-1246221

Source DB:  PubMed          Journal:  Skull Base        ISSN: 1531-5010


  17 in total

1.  Head and neck osteosarcoma at the University of Washington.

Authors:  D Oda; L M Bavisotto; R A Schmidt; M McNutt; J D Bruckner; E U Conrad; E A Weymuller
Journal:  Head Neck       Date:  1997-09       Impact factor: 3.147

2.  Osteosarcomas and chondrosarcomas of the jaws: immunohistochemical correlations.

Authors:  J A Regezi; R J Zarbo; K D McClatchey; R M Courtney; J D Crissman
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1987-09

3.  Osteosarcoma of the jaw bones. Long-term follow up of 48 cases.

Authors:  R J van Es; R B Keus; I van der Waal; R Koole; A Vermey
Journal:  Int J Oral Maxillofac Surg       Date:  1997-06       Impact factor: 2.789

Review 4.  Osteogenic sarcoma of the jaws: factors influencing prognosis.

Authors:  M August; P Magennis; D Dewitt
Journal:  Int J Oral Maxillofac Surg       Date:  1997-06       Impact factor: 2.789

5.  Osteosarcoma of the head and neck: a review of the Johns Hopkins experience.

Authors:  P K Ha; D W Eisele; F J Frassica; M L Zahurak; E F McCarthy
Journal:  Laryngoscope       Date:  1999-06       Impact factor: 3.325

6.  Osteogenic sarcoma of the mandible and maxilla: a Canadian review (1980-2000).

Authors: 
Journal:  J Otolaryngol       Date:  2004-06

7.  Osteosarcoma of the head and neck: meta-analysis of nonrandomized studies.

Authors:  R R Kassir; C H Rassekh; J B Kinsella; J Segas; R L Carrau; J A Hokanson
Journal:  Laryngoscope       Date:  1997-01       Impact factor: 3.325

8.  Angiographic balloon test occlusion and therapeutic sacrifice of major arteries to the brain.

Authors:  Angelika Sorteberg; Søren Jacob Bakke; Morten Boysen; Wilhelm Sorteberg
Journal:  Neurosurgery       Date:  2008-10       Impact factor: 4.654

9.  Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study group.

Authors:  Sven Jasnau; Ulrich Meyer; Jenny Potratz; Gernot Jundt; Matthias Kevric; Ulrich K Joos; Heribert Jürgens; Stefan S Bielack
Journal:  Oral Oncol       Date:  2007-04-27       Impact factor: 5.337

10.  A combined epi- and subdural direct approach to carotid-ophthalmic artery aneurysms.

Authors:  V V Dolenc
Journal:  J Neurosurg       Date:  1985-05       Impact factor: 5.115

View more
  1 in total

1.  Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years.

Authors:  Marton König; Terje A Osnes; Ingvild Lobmaier; Bodil Bjerkehagen; Øyvind S Bruland; Kirsten Sundby Hall; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2016-11-17       Impact factor: 3.042

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.